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Coronaviruses attach to host cell surface receptors via their spike (S) proteins to mediate the entry
into the host cell. The S1 coronavirus subunit of S-proteins contains the receptor-binding domain
(RBD) that is able to recognize different host receptors, highlighting its remarkable capacity to
adapt to their hosts along the viral evolution. While RBD in spike proteins is determinant for
the virus-receptor interaction, the active residues lie at the receptor-binding motif (RBM), which is
part of RBD and plays a fundamental role binding the outer surface of their receptors. Here, we
address the hypothesis that SARS-CoV and SARS-CoV-2 strains able to use angiotensin-converting
enzyme 2 (ACE2) proteins have adapted their RBM along the viral evolution to explore specific
conformational topology driven by the amino acid residues YGF to infect host cells. We also
speculate that this YGF-based mechanism can act as a protein signature located at the RBM to
distinguish coronaviruses able to use ACE2 as a cell entry receptor.
INTRODUCTION
Viruses are the most numerous type of biological entity
on Earth and the identification of novel viruses contin-
ues to enlarge the known viral biosphere [1, 2]. This
collection of all viruses presents enormous morphological
and genomic diversity as a result of continuous exchange
of genetic material with the host cells [3, 4]. Moreover,
this well succeeded long-term virus-host interaction in-
dicates that viruses are more than simple genomic para-
sites in all cellular life forms [5]. A number of evidences
has led to the proposal that viruses play an astonish-
ing role as agents of evolution because of their capacity
in propagating between biomes [6] and in gene transfer
between species [7–10]. For this purpose, viruses have
developed large number of genome replication and pro-
tein expression strategies to benefit from the host trans-
lational machinary over time [11].
Despite all of such enormous diversity in gene sequence,
it is not possible to achieve huge number of highly distinct
protein structures mainly because of stereochemical con-
straints on the possible protein folds [12]. In fact, it has
been observed common secondary structures throughout
different virus families while the sequences are not fully
conserved [12, 13]. This may result in evolutionary ef-
ficiency once viruses can exploit already well designed
motifs from similar cellular functions [11].
Currently, the world population is confronting a new
coronavirus disease (COVID-19), a highly infectious dis-
ease to humans. This disease is caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) and
is affecting human health worldwide. Coronaviruses
(CoVs) belong to the large and diverse family Coro-
naviridae, within the order Nidovirales and suborder
Cornidovirineae [14]. Their subfamily Orthocoronaviri-
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nae contains four genera based on phylogeny and termed
as α, β, γ, and δ-coronavirus.
SARS-CoV-2 belongs to the β-coronavirus genus as
well as SARS-CoV, middle east respiratory syndrome
coronavirus (MERS-CoV), and hCoV-HKU1, to cite
a few [15]. Other important representative viruses
as human hCoV-NL63 and hCoV-229E belong to α-
coronavirus. Phylogenetic relationships among the
known members of this subfamily indicate that α and β-
coronavirus infect mammals, while γ and δ-coronavirus
infect both mammalians and avians.
Members of Coronaviridae family are enveloped, pos-
itive single-stranded RNA (+ssRNA) viruses and ren-
der the largest genomes among all known RNA viruses
[16–19]. The +ssRNA genomes undergo rapid muta-
tional changes [20], leading to faster adaptation to new
hosts, though also contain conserved sequence motifs as
observed, for example, in multiple alignments do CoV
strains [13, 21, 22].
Coronaviruses attach to host cell surface receptors via
their spike (S) glycoproteins, located on the viral en-
velope, to mediate the entry into the host cell. Each
monomer of trimeric S-protein comprises two subunits
S1 and S2, responsible for the viral attachment and for
the membrane fusion, respectively [23–25]. The S1 coro-
navirus subunit contains the receptor-binding domain
(RBD) that is able to recognize different host receptors,
highlighting its remarkable capacity to adapt to their
hosts along the viral evolution. Thus, it is not unex-
pected to observe in this domain high sequence diver-
gence even for the same coronavirus identified in differ-
ent host species. In contrast, the S2 subunit presents the
most conserved region in the S-protein.
The binding of RBD spike proteins to the receptor on
the host cell is the first step in virus infection. This ini-
tial step is followed by an entry mechanism of enveloped
viruses into target cells. Usually, most viruses enter cells
through endocytotic pathways with the fusion occurring
in the endosomes, although a direct entry into cells can
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2occur by fusion of their envelopes with the cell membrane
[26].
A number of CoVs utilizes angiotensin-converting en-
zyme 2 (ACE2) as the entry receptor into cells, exempli-
fied by β-genus human respiratory SARS-CoV, SARS-
CoV-2, and α-genus hCoV-NL63 [15, 27–29]. In par-
ticular, SARS-CoV, as well as SARS-CoV-2, enter the
cell via endocytosis induced by RBD complexed with hu-
man ACE2 (hACE2) receptor [30–34]. In contrast, the
β-genus MERS-CoV and its genetically related bat CoV-
HKU4 utilize dipeptidyl peptidase 4 (DPP4) as the viral
receptor [35]. Other viral receptor is aminopeptidase N
(APN), recognized for example by the α-genus hCoV-
229E [36].
The human coronaviruses hCoV-HKU1, hCoV-229E,
hCoV-NL63, and hCoV-OC43, cause mild to moder-
ate upper respiratory tract infections [37], while SARS-
CoV and SARS-CoV-2 cause severe respiratory diseases,
with SARS-CoV-2 being far more lethal than SARS-CoV.
SARS-CoV strains vary enormously in infectivity, which
can be connected to their binding affinities to hACE2
[38]. This binding affinity, in turn, can be correlated
with disease severity in humans [39].
While RBD in spike proteins is determinant for the
virus-receptor interaction, the active residues lie at the
receptor-binding motif (RBM), which is part of RBD
and plays a fundamental role binding the outer surface
of their receptors [27, 28, 38, 40, 41]. The importance
of the RBM is further explored here in relation to its
structural topology. Thus, instead of analysing specific
residues that make contacts with ACE2 after binding,
we followed the molecular origin that drives the viral at-
tachment to this cell receptor. This investigation has
revealed a highly conserved amino acid residue sequence
Tyr-Gly-Phe (YGF) in coronavirus variants that employ
this receptor. Thus, we hypothesize that the short se-
quence YGF is vital for RBD-ACE2 interaction because
of the formation of the hydrophobic pocket proper to the
receptor specificity [40, 42–44], as exposed next. It is
likely that SARS-CoV and SARS-CoV-2 strains able to
use ACE2 proteins have adapted their RBM along the
viral evolution to explore this YGF-based mechanism to
infect host cells.
The conserved XGF loop in UBA-ubiquitin
interaction
Amino acid sequences of type XGF, where the residue
X is frequently the residue Met, form a highly conserved
loop characteristic of ubiquitin-associated (UBA) domain
that occurs in a variety of proteins. The UBA do-
main is a conserved motif through eukaryotic evolution
and is found in many proteins related to the ubiquitin
metabolism and in particular, associated with ubiquitin-
mediated proteolysis [45, 46]. The MGF loop in the UBA
domain is typical of a hydrophobic pocket that is critical
for recognition and binding affinity to ubiquitin through
a hydrophobic surface patch located in the vicinity of this
loop [47–54].
NMR analyses of UBA-ubiquitin interactions iden-
tify hydrophobic surface patches formed by the con-
served MGF sequence as the main determinants for
the dimerization interface. A number of alignments
of p62/SQSTM1 UBA domain with other UBA-domain
proteins has revealed single-point mutation in the MGF
sequence, mainly M→L, or F→Y, maintaining its overall
hydrophobic characteristic [55].
RESULTS AND DISCUSSION
Spike receptor-binding motifs in human CoVs
Here, we examine the occurrence and importance of the
specific amino acid residue sequence YGF for SARS-CoV
and SARS-CoV-2 strains able to use ACE2 proteins as
receptors. It is displayed in Fig 1a the interface of SARS-
CoV RBD spike-protein (magenta and green color) com-
plexed with hACE2 (blue color) to gain insight about
the importance of this kind of conformational mecha-
nism in creating a shape complementarity between re-
ceptor and ligand. The RBM is in magenta color, with
the yellow color displaying the YGFY sequence in that
pocket, which establishes the proper relative position for
favorable binding to ACE2 exposed residues. The YGFY
sequence seems strongly conserved for many SARS-CoV.
It is located at residues 481-484 in RBM. Noteworthy,
no other GF sequence occurs in this region, neither in
its RBD. As a consequence of this hydrophobic pocket,
amino acid residues responsible for binding interaction
are located close to this conformational structure. For
instance, the residues N479 and T487, which have been
identified to be essential for receptor binding [39, 41, 56].
The residue N479 in SARS-CoV is located near K31 of
hACE2 and makes a salt bridge with E35, a residue
buried in that hydrophobic environment. The residue
T487 is located close to K353 on hACE2, and in turn
makes a salt-bridge with D38, also buried in that pocket
(Fig 2a). Other important residues for this attachment
are Y442, L472, and D480 [40].
Figure 1b displays the interface of SARS-CoV-2 RBD
spike-protein complexed with hACE2, also in blue color.
Now, the sequence YGFY observed in SARS-CoV is re-
placed by YGFQ (Fig 3). The single-point mutation
Y484→Q498 replaces a hydrophobic residue in SARS-
CoV by a hydrophilic one in SARS-CoV-2.
Figure 3 compares amino acid sequences of human
SARS-CoV and SARS-CoV-2 strains aligned with RBM
of SARS-CoV Tor2, an epidemic strain isolated from hu-
mans during the SARS epidemic in 2002-2003. The hu-
man Tor2 strain has high affinity for hACE2 [38]. We
highlight in Fig 3 in medium purple color the hydropho-
bic sequence YGFY typical of SARS-CoV, occurring at
positions 481-484 in the spike protein. The correspond-
ing mutated sequence occurs now at positions 495-498 in
3Figure 1. Detailed surface view of SARS-CoV and SARS-CoV-2. (a) Residues YGFY at the interface of SARS-CoV
complexed with human ACE2 (PDB ID: 2AJF). These residues are in yellow color and form a hydrophobic pocket located in
the RBM (magenta color). (b) Residues YGF and EGF (yellow color) at the interface of SARS-CoV-2 complexed with human
ACE2 (PDB ID: 6LZG). The first sequence is located in a hydrophobic pocket, while the second sequence EGF is on the RBM
surface (magenta color). Ribbon representation of ACE2 is in blue color.
Figure 2. SARS-CoV and SARS-CoV-2/ACE2 interfaces. Ribbon diagrams of SARS-CoV (a) and SARS-CoV-2 (b)
complexed with human ACE2 (blue color), where the RBM is highlighted in magenta color. The main residues responsible for
the structural binding are displayed in the stick representation.
SARS-CoV-2 spike protein.
The important residues for the interface in-
teraction found in SARS-CoV are mutated in
SARS-CoV-2. The sequence alignments show the
mapping, Y442→L455, L472→F486, N479→Q493,
D480→S494, and T487→N501. These mutations do
not present a drastic change in their hydrophobic char-
acter [57], thus preserving the overall receptor-binding
topological structure for these viruses. In particular,
residues L455 and Q493 in SARS-CoV-2 preserve the
noted favourable interactions with the residues E35 and
K31 in hACE2 [58] (Fig 2b). Interestingly, a new GF
sequence appears in the RBM of SARS-CoV-2 strains as
a consequence of the mutation L472→F486, producing a
small hydrophobic surface, but does not seem to disrupt
the proposed topological formation mechanism for ACE2
4Figure 3. Sequence alignments of human CoVs restricted to RBM residues. The medium purple color highlights
the YGFY pattern followed by the mutation Y498Q in the RBM of SARS-CoV-2 strains.
Figure 4. Sequence alignment of bat CoVs restricted to RBM residues of SARS-CoV Tor2. The residues of YGFY
pattern are in medium purple color. Last three alignments are placed together for direct amino acid sequence comparison.
binding. No other GF sequence appears in their RBD.
Details of protein-protein binding interfaces can be
quite different among strains, likely related to their infec-
tivity degree. It has been noted that mutations in RBM
residue T487 have an important role in the human-to-
human and animal-to-human transmission of SARS-CoV
[36, 38, 56].
Spike receptor-binding motifs in bats
It is known that not all SARS-CoV strains isolated
from bat hosts have exploited ACE2 as a cellular at-
tachment. Therefore, the set of amino acid sequences
displayed in Fig 4 may exemplify the successful rela-
tion between virus evolution and the binding mechanism.
This set highlights in medium purple color the preserved
amino acid residues in the sequence YGFY, characteris-
tics of human SARS-CoV. For comparison, we also dis-
play CoV strains with mutations in that SARS-CoV pat-
tern to explore the relation between the hypothesized
mechanism and the cell receptor recognition.
It has been demonstrated that LYRa11 [28], Rs3367
[59], Rs4874 [60], WIV1, and WIV16 [28, 61], have the
capacity to use ACE2 for cell entry, in line with our hy-
pothesis. Also, the near single-point mutation Y→F in
5Figure 5. Sequence alignment of palm civet CoVs and pangolin PCoVs restricted to RBM residues of SARS-
CoV Tor2. The residues of YGFY pattern are in medium purple color. Last line includes the SARS-CoV-2 sequence for
comparison.
the next six strains does not interfere, as expected, in the
attachment mechanism. This remark is supported by cell
entry studies for Rs7327 [28, 60], Rs9401, RsSHC014,
Rs4084, and Rs4231 [60], because they are in a group
that is likely to use the ACE2 receptor. Moreover, this
mutation replaces a hydrophobic residue by another one
with higher hydrophobicity, reinforcing the conforma-
tional topology for binding with the receptor.
The next group corresponds to the mutation Y→T,
decreasing the initial hydrophobicity of the expected
pocket. It seems unlikely that this mutation and amino
acid residue deletions in the RBM associated to Tor2
sequence affect the YGF-based attachment mechanism
for BtKY72 and BB9904/BGR. However, there is no
available experimental data concerning their receptors.
It is important to remark that the residue F492 in
BM48-31/BGR produces another hydrophobic sequence
IGF at residues 490-492 (Fig 4). We speculate that this
double occurrence may disrupt the aforementioned mech-
anism because of indications that BM48-31/BGR does
not interact, at least with human ACE2 [28]. No other
GF sequence occurs for these strains in the RBM nor in
their RBD.
Next CoV strains do not contain such GF sequences
of residues in the RBM neither in their RBD, except
Rf1/2004, which is located in RBD and with GF sur-
rounded by hydrophilic residues. Although we have con-
sidered only part of their sequences that better align
with RBM of Tor2, it has been demonstrated that the
spikes of HuB2013, HKU3, CoVZC45, CoVZXC21, Rf1,
Rf4092, and Shaanxi2011 do not use hACE2, a result
that is not just a consequence of deletions at the RBD
[28]. Further support has been presented against HKU3
in using hACE2 [62]. It seems unlikely that Rm1/2004
infects hACE2 because its unfavourable binding free en-
ergy [63]. Another result concludes that Rp3 is unable of
infect hACE2 or even bat ACE2 [64].
We have placed together the alignments involving
Tor2, RaTG13, and SARS-CoV-2 at the end of Fig 4
for further comparison. The whole genome of RaTG13
shares 96% amino acid sequence identity with SARS-
CoV-2, and it is considered the most closely related
genome to this CoV [65]. Considering its spike pro-
tein, and RBM, RaTG13 shares respectively 97% and
76% amino acid identity with SARS-CoV-2. For com-
parison, RaTG13 shares 79%, 77%, and 53% identity,
respectively, for the whole genome, spike protein, and
RBM with SARS-CoV Tor2. Therefore, SARS-CoV-2 is
mostly similar to RaTG13 than SARS-CoV strains in all
regions.
Spike receptor-binding motifs in palm civets and
pangolins
To explore further the role of YGF-based attachment
mechanism, we exhibit comparative residue sequences for
civet and pangolins, again aligned with RBM of SARS-
CoV Tor2 (Fig 5). This figure shows that the pattern
YGFY characteristic of human SARS-CoV is maintained
for the collected data, but with a single-point mutation
Y→H for pangolin hosts PCoV. No other GF sequence
occurs even in the RBD of these strains.
We have included SARS-CoV-2 on the last line of
Fig 5 for a direct comparison. PCoV GX-P2V shares
79%, 77%, and 50% amino acid identity with Tor2, re-
spectively for whole genome, spike protein, and RBM
aligned with Tor2. In relation to SARS-CoV-2, PCoV
GX-P2V shares 85%, 92%, and 75% amino acid identity,
respectively for whole genome, spike protein, and RBM.
It is believed that human SARS-CoV passed from palm
civets to humans in the 2002-2003 epidemic because their
genome sequences are highly similar [38, 56, 66]. The
amino acid alignments show an almost identical RBM
6between human SARS-CoV, represented by Tor2 strain,
and collected data from palm civet strains. This identi-
fication also includes the YGF-based mechanism able to
use ACE2 proteins. Nevertheless, these alignments dis-
play high similarity between pangolins and SARS-CoV-
2, which also support previous conclusions on pangolins
being the probable origin of SARS-CoV-2 [65, 67]. How-
ever, based on our data related to host receptor binding
and their RBM and S-protein alignments, we can not dis-
card bat RaTG13-like strain as also the possible origin
of SARS-CoV-2.
SARS-CoV and hCoV-NL63: only functionally
related
Although there is no many available experimental data
identifying the viral receptor-binding protein for CoVs, it
is well established that human SARS-CoV and hCoV-
NL63 both employ ACE2 as the cell receptor to in-
fect host cells [68, 69]. Interestingly, SARS-CoV and
hCoV-NL63 domains do not present high sequence sim-
ilarity. For example, their spike-S1 subunities share
only 10% in similarity. Other features separate SARS-
CoV and hCoV-NL63 [70]. SARS-CoVs are classified as
β-coronavirus with subgenus sarbecovirus, while hCoV-
NL63 is in genus α-coronavirus and subgenus setra-
covirus. Although hCoV-NL63 also enters the cell via en-
docytosis, its functional receptor requires heparan sulfate
proteoglycans for the initial attachment, representing an
important extra factor for ACE2 act as a functional re-
ceptor [33, 70]. Moreover, the spike-S1 glycoprotein of
SARS-CoV binds more efficiently ACE2 than the corre-
sponding spike-S1 of NL63 (NL63-S) [71]. This may be
linked to the fact that SARS-CoV and NL63-S contact
hACE2 differently, a conclusion based upon the exper-
imental results that NL63-S does not bind to hACE2
through a single and large domain [69, 72]. Actually,
different RBD regions have been identified within NL63-
S. One of these regions was positioned at residues 476-
616 and comprising three discontinuous RBM regions,
RBM1 (residues 497-501), RBM2 (residues 530-540), and
RBM3 (residues 575-594) [73–75]. A slightly different
RBD has been identified for this CoV [72]. It would be
located at residues 482-602, also with three discontin-
uous RBM regions, which surround a shallow cavity at
hCoV-NL63-ACE2 binding interface. Curiously, its spike
protein alignment with Tor2 does not show the expected
residue pattern in the corresponding RBM of Tor2 nor
in the aforementioned RBD regions of NL63-S. This may
help to explain the unusual pathway of binding to ACE2
for this CoV.
METHODS
All sequences were analysed with ClustalW and
Jalview. The list of GenBank accession codes for the
spike proteins analysed in this work is available in
supplementary Table S1.
CONCLUSION
We have analysed a number of CoV strains to support
the hypothesis that SARS-CoV and SARS-CoV-2 strains
share a common evolutionary mechanism for the initial
attachment to ACE2. Moreover, we speculate that the
YGF-based mechanism can act as a protein signature to
distinguish CoVs able to use ACE2 as a cell entry re-
ceptor whenever this residue sequence is located at the
CoV RBM region. For example, SARSr-CoV ZXC21 and
ZC45, the closely related spike sequences to SARS-CoV-
2, can be promptly put under suspicious in their ACE2
binding affinity. Of course, as exemplified by hCoV-
NL63, we can not discard that another mechanism can
act helping such binding. It must be accentuated that
the occurrence of other XGF sequences, mainly with X
being a hydrophobic residue, in the RBM, or even in the
RBD region, is likely to disrupt the proposed topological
mechanism for ACE2 binding. This because it might
introduce hydrophobic loops promoting a new ligand-
substrate recognition.
SUPPORTING INFORMATION
Table S1 GenBank accession numbers for the
coronavirus sequences used in this study.
Acknowledgements
P.P.D.C. and N.A.A. gratefully acknowledge financial
supports from the Brazilian agencies CAPES, and
FAPESP, process 2015/16116-3, respectively.
Competing interests The authors declare no com-
peting financial interests.
[1] Pan D, Nolan J, Williams KH, Robbins MJ, Weber KA.
Abundance and distribution of microbial cells and viruses
in an alluvial aquifer. Front Microbiol. 2017; 8:1199.
https://doi.org/10.3389/fmicb.2017.01199
[2] Shi M, Lin X-D, Chen X, Tian J-H, Chen L-J, Li K, et al.
The evolutionary history of vertebrate RNA viruses. Na-
ture. 2018; 556:197-202. https://doi.org/10.1038/s41586-
018-0012-7
7[3] Nasir A, Forterre P, Kim KM, Caetano-Anollés
G. The distribution and impact of viral lineages
in domains of life. Front Microbiol. 2014; 5:194.
https://doi.org/10.3389/fmicb.2014.00194
[4] Koonin EV, Dolja VV, Krupovic M, Varsani A,
Wolf YI, Yutin N, et al. Global organization
and proposed megataxonomy of the virus world.
Microbiol Mol Biol Rev. 2020; 84(2):e00061-19.
https://doi.org/10.1128/MMBR.00061-19
[5] Claverie JM. Viruses take center stage in cel-
lular evolution. Genome Biol. 2006; 7:110.
https://doi.org/10.1186/gb-2006-7-6-110
[6] Sano E, Carlson S, Wegley L, Rohwer F.
Movement of viruses between biomes. Ap-
plied Environmental Microb. 2004; 70:5842-46.
https://doi.org/10.1128/aem.70.10.5842-5846.2004
[7] Van Blerkom LM. Role of viruses in human evo-
lution. Yearbook Phys Anthropology. 2003; 46:14-46.
https://doi.org/10.1002/ajpa.10384
[8] Filée J, Forterre P, Laurent J. The role played by
viruses in the evolution of their hosts: a view based
on informational protein phylogenies. Research Microbi-
ology. 2003; 154:237-43. https://doi.org/10.1016/S0923-
2508(03)00066-4
[9] Koonin EV, Dolja VV. A virocentric perspective on the
evolution of life. Curr Opinion Virol. 2013; 3:546-57.
http://doi.org/10.1016/j.coviro.2013.06.008
[10] Enard D, Cai L, Gwennap C, Petrov DA. Viruses are a
dominant driver of protein adaptation in mammals. eLife.
2016; 5:e12469. http://doi.org/10.7554/eLife.12469.001
[11] Baranowski E, Ruiz-Jarabo CM, Pariente N, Verda-
guer N, Domingo E. Evolution of cell recognition by
viruses: a source of biological novelty with medi-
cal implications. Advances Virus Res. 2003; 62:19-111.
https://doi.org/10.1016/S0065-3527(03)62002-6
[12] Ng WM, Stelfox AJ, Bowden TA. Unraveling
virus relationships by structure-based phyloge-
netic classification. Virus Evol. 2020; 6:veaa003.
https://doi.org/10.1093/ve/veaa003
[13] Ahola T, Karlin DG. Sequence analysis reveals a con-
served extension in the capping enzyme of the alphavirus
supergroup, and a homologous domain in nodaviruses.
Biol Direct. 2015; 10:16. https://doi.org/10.1186/s13062-
015-0050-0
[14] Gorbalenya AE, Baker SC, Baric RS, de Groot RJ,
Drosten C, Gulyaeva AA, et al. The species Severe
acute respiratory syndrome-related coronavirus: classi-
fying 2019-nCoV and naming it SARS-CoV-2. Nat Mi-
crobiol. 2020; 5:536-44. https://doi.org/10.1038/s41564-
020-0695-z
[15] Jaimes JA, André NM, Chappie JS, Millet JK,
Whittaker GR. Phylogenetic analysis and struc-
tural modeling of SARS-CoV-2 spike protein reveals
an evolutionary distinct and proteolytically sensi-
tive activation loop. J Mol Biol. 2020; 432:3309-25.
https://doi.org/10.1016/j.jmb.2020.04.009
[16] Masters PS. The molecular biology of coro-
naviruses. Adv Virus Res. 2006; 66:193-292.
https://doi.org/10.1016/S0065-3527(06)66005-3
[17] Cheng VCC, Lau SKP, Woo PCY, Yuen KY.
Severe acute respiratory syndrome coronavirus
as an agent of emerging and reemerging infec-
tion. Clinical Microbiol Rev. 2007; 20(4):660-694.
https://doi.org/10.1128/CMR.00023-07
[18] Su S, Wong G, Shi W, Liu J, Lai ACK, Zhou J, et al.
Epidemiology, genetic recombination, and pathogenesis
of coronaviruses. Trends Microbiol. 2016; 24(6):490-502.
http://doi.org/10.1016/j.tim.2016.03.003
[19] Li F. Structure, function, and evolution of coron-
avirus spike proteins. Annu Rev Virol. 2016; 3:237-
261. https://doi.org/10.1146/annurev-virology-110615-
042301
[20] Sanjuán R, Domingo-Calap P. Mechanisms of vi-
ral mutation. Cell Mol Life Sci. 2016; 73:4433-4448.
https://doi.org/10.1007/s00018-016-2299-6
[21] Lau SKP, Woo PCY, Li KSM, Huang Y., Wang M,
Lam CSF, et al. Complete genome sequence of bat coro-
navirus HKU2 from chinese horseshoe bats revealed a
much smaller spike gene with a different evolutionary lin-
eage from the rest of the genome. Virol. 2007; 367:428-
439. https://doi.org/10.1016/j.virol.2007.06.009
[22] Woo PCY, Lau SKP, Lam CSF, Lau CCY, Tsang
AKL, Lau JHN, et al. Discovery of seven novel mam-
malian and avian coronaviruses in the genus delta-
coronavirus supports bat coronaviruses as the gene
source of alphacoronavirus and betacoronavirus and
avian coronaviruses as the gene source of gammacoron-
avirus and deltacoronavirus. J Virol. 2012; 86:3995-4008.
http://doi.org/10.1128/JVI.06540-11
[23] Beniac DR, Andonov A, Grudeski E, Booth TF.
Architecture of the SARS coronavirus prefusion
spike. Nature Struct Mol Biol. 2006; 13(8):751-752.
http://doi.org/10.1038/nsmb1123
[24] Li F. Evidence for a common evolutionary origin of coro-
navirus spike protein receptor-binding subunits. J Virol.
2012; 86:2856-2858. http://doi.org/10.1128/JVI.06882-
11
[25] Song W, Gui M, Wang X, Xiang Y. Cryo-EM
structure of the SARS coronavirus spike gly-
coprotein in complex with its host cell recep-
tor ACE2. PLoS Pathog. 2018; 14:e1007236.
https://doi.org/10.1371/journal.ppat.1007236
[26] Belouzard S, Millet JK, Licitra BN, Whittaker GR.
Mechanisms of coronavirus cell entry mediated by
the viral spike protein. Viruses. 2012; 4:1011-33.
https://doi.org/10.3390/v4061011
[27] Hoffmann M, Kleine-Weber H, Schroeder S, Krüger N,
Herrler T, Erichsen S, et al. SARS-CoV-2 cell entry de-
pends on ACE2 and TMPRSS2 and is blocked by a clin-
ically proven protease inhibitor. Cell. 2020; 181:271-280.
https://doi.org/10.1016/j.cell.2020.02.052
[28] Letko M, Marzi A, Munster V. Functional assessment of
cell entry and receptor usage for SARS-CoV-2 and other
lineage B betacoronaviruses. Nature Microbiol. 2020;
5:562-69. https://doi.org/10.1038/s41564-020-0688-y
[29] Walls AC, Park YJ, Tortorici MA, Wall A, McGuire AT,
Veesler D. Structure, Function, and Antigenicity of the
SARS-CoV-2 Spike Glycoprotein. Cell. 2020; 180:281-
292. https://doi.org/10.1016/j.cell.2020.02.058.
[30] Wang H, Yang P, Liu K, Guo F, Zhang Y,
Zhang G, et al. SARS coronavirus entry into
host cells through a novel clathrin- and caveolae-
independent endocytic pathway. Cell Res. 2008; 18:290-
301. https://doi.org/10.1038/cr.2008.15
[31] Wang S, Guo F, Liu K, Wang H, Rao S, Yang
P, et al. Endocytosis of the receptor-binding do-
main of SARS-CoV spike protein together with
virus receptor ACE2. Virus Research. 2008; 136:8-15.
8https://doi.org/10.1016/j.virusres.2008.03.004
[32] Yuan Y, Cao D, Zhang Y, Ma J, Qi J, Wang Q,
et al. Cryo-EM structures of MERS-CoV and SARS-
CoV spike glycoproteins reveal the dynamic recep-
tor binding domains. Nature Commun. 2017; 8:15092.
https://doi.org/10.1038/ncomms15092
[33] Milewska A, Nowak P, Owczarek K, Szczepanski A,
Zarebski M, Hoang A, et al. Entry of human coron-
avirus NL63 into the cell. J Virol. 2018; 92:e01933-17.
https://doi.org/10.1128/JVI.01933-17
[34] Ou X, Liu Y, Lei X, Li P, Mi D, Ren L, et
al. Characterization of spike glycoprotein of SARS-
CoV-2 on virus entry and its immune cross-reactivity
with SARS-CoV. Nature Commun. 2020; 11:1620.
https://doi.org/10.1038/s41467-020-15562-9
[35] Yang Y, Du L, Liu C, Wang L, Ma C, Tang
J, et al. Receptor usage and cell entry of bat
coronavirus HKU4 provide insight into bat-to-
human transmission of MERS coronavirus. Proc
Natl Acad Sci USA. 2014; 111:12516-12521.
http://www.pnas.org/cgi/doi/10.1073/pnas.1405889111
[36] Li F. Receptor recognition mechanisms of coronaviruses:
a decade of structural studies. J Virol. 2015; 89:1954-
1964. http://dx.doi.org/10.1128/JVI.02615-14
[37] Weiss SR, Navas-Martin S. Coronavirus pathogenesis and
the emerging pathogen severe acute respiratory syndrome
coronavirus. Microbiol Mol Biol Rev. 2005; 69:635-664.
https://doi.org/10.1128/MMBR.69.4.635-664.2005
[38] Cui J, Li F, Shi Z-L. Origin and evolution of pathogenic
coronaviruses. Nature Rev Microbiol. 2019; 17:181-192.
https://doi.org/10.1038/s41579-018-0118-9
[39] Li W, Zhang C, Sui J, Kuhn JH, Moore MJ, Luo S, et
al. Receptor and viral determinants of SARS-coronavirus
adaptation to human ACE2. EMBO J. 2005; 24(8):1634-
1643. https://doi.org/10.1038/sj.emboj.7600640
[40] Wan Y, Shang J, Graham R, Baric RS, Li F. Recep-
tor recognition by the novel coronavirus from Wuhan:
an analysis based on decade-long structural studies
of SARS coronavirus. J Virol. 2020; 94:e00127-20.
https://doi.org/10.1128/JVI.00127-20
[41] Li F, Farzan M, Harrison SC. Structure of SARS
coronavirus spike receptor-binding domain com-
plexed with receptor. Science. 2005; 309:1864-1868.
https://doi.org/10.1126/science.1113611
[42] Wu K, Peng G, Wilken M, Geraghty RJ, Li F. Mecha-
nisms of host receptor adaptation by severe acute respira-
tory syndrome coronavirus. J Biol Chem. 2012; 287:8904-
11. https://doi.org/10.1074/jbc.M111.325803.
[43] Lan J, Ge J, Yu J, Shan S, Zhou H, Fan S, et al. Struc-
ture of the SARS-CoV-2 spike receptor-binding domain
bound to the ACE2 receptor. Nature. 2020; 581:215-228.
https://doi.org/10.1038/s41586-020-2180-5.
[44] He J, Tao H, Yan Y, Huang S-Y, Xiao Y. Molecular mech-
anism of evolution and human infection with SARS-CoV-
2. Viruses. 2020; 12:428. https://doi:10.3390/v12040428
[45] Pickart CM, Cohen RE. Proteasomes and their kin: pro-
teases in the machine age. Nature Rev Mol Cell Biol.
2004; 5:177-187. https://doi.org/10.1038/nrm1336
[46] Finley D. Recognition and processing of
ubiquitin-protein conjugates by the protea-
some. Annu Rev Biochem. 2009; 78:477-513.
https://doi.org/10.1146/annurev.biochem.78.081507.101607
[47] Dieckmann T, Withers-Ward ES, Jarosinski MA, Liu
C-F, Chen ISY, Feigon J. Structure of a human DNA
repair protein UBA domain that interacts with HIV-
1 Vpr. Nature Struct Biol. 1998; 5(12):1042-1047.
https://doi.org/10.1038/4220
[48] Wilkinson CRM, Seeger M, Hartmann-Petersen R, Stone
M, Wallace M, Semple C, et al. Proteins contain-
ing the UBA domain are able to bind to multi-
ubiquitin chains. Nature Cell Biol. 2001; 3:939-943.
https://doi.org/10.1038/ncb1001-939
[49] Bertolaet BL, Clarke DJ, Wolff M, Watson M,
Henze M, Divita G, et al. UBA domains mediate
protein-protein interactions between two DNA damage-
inducible proteins. J Mol Biol. 2001; 313:955-963.
https://doi.org/10.1006/jmbi.2001.5105
[50] Madura K. The ubiquitin-associated (UBA) domain: On
the path from prudence to prurience Cell Cycle. 2002;
1:235-244. https://doi.org/10.4161/cc.1.4.130
[51] Raasi S, Varadan R, Fushman D, Pickart CM. Di-
verse polyubiquitin interaction properties of ubiquitin-
associated domains. Nature Struct Mol Biol. 2005;
12:708-714. https://doi.org/10.1038/nsmb962
[52] Long J, Gallagher TRA, Cavey JR, Sheppard PW, Ral-
ston SH, Layfield R, et al. Ubiquitin recognition by the
ubiquitin-associated domain of p62 involves a novel con-
formational switch. J Biol Chem. 2008; 283:5427-5440.
https://doi.org/10.1074/jbc.M704973200
[53] Tse MK, Hui SK, Yang Y, Yin S-T, Hu H-Y,
Zou B, et al. Structural analysis of the UBA do-
main of X-linked inhibitor of apoptosis protein
reveals different surfaces for ubiquitin-binding and
self-association. PLoS ONE. 2011; 6(12):e28511.
https://doi.org/10.1371/journal.pone.0028511
[54] Cabe M, Rademacher DJ, Karlsson AB, Cherukuri S,
Bakowska JC. PB1 and UBA domains of p62 are es-
sential for aggresome-like induced structure formation.
Biochem Biophys Res Commun. 2018; 503:2306-2311.
https://doi.org/10.1016/j.bbrc.2018.06.153
[55] Geetha T, Wooten MW. Structure and functional prop-
erties of the ubiquitin binding protein p62. FEBS
Lett. 2002; 512:19-24. https://doi.org/10.1016/S0014-
5793(02)02286-X
[56] Qu X-X, Hao P, Song X-J, Jiang S-M, Liu Y-
X, Wang P-G, et al. Identification of two critical
amino acid residues of the severe acute respiratory
syndrome coronavirus spike protein for its variation
in zoonotic tropism transition via a double substitu-
tion strategy. J Biol Chem. 2005; 280(33):29588-29595.
https://doi:10.1074/jbc.M500662200
[57] Wimley WC, White SH. Experimentally determined
hydrophobicity scale for proteins at membrane in-
terfaces. Nature Struc Biol. 1996; 3(10):842-848.
https://doi.org/10.1038/nsb1096-842
[58] Yi C, Sun X, Ye J, Ding L, Liu M, Yang Z, et al. Key
residues of the receptor binding motif in the spike pro-
tein of SARS-CoV-2 that interact with ACE2 and neu-
tralizing antibodies. Cell Mol Immunol. 2020; 17:621-630.
https://doi.org/10.1038/s41423-020-0458-z
[59] Ge X-Y, Li J-L, Yang X-L, Chmura AA, Zhu G, Epstein
JH, et al. Isolation and characterization of a bat SARS-
like coronavirus that uses the ACE2 receptor. Nature.
2013; 503:535-538. https://doi:10.1038/nature12711
[60] Hu B, Zeng L-P, Yang X-L, Ge X-Y, Zhang W, Li B, et
al. Discovery of a rich gene pool of bat SARS-related
coronaviruses provides new insights into the origin of
SARS coronavirus. PLoS Pathog. 2017; 13(11):e1006698.
9https://doi.org/10.1371/journal.ppat.1006698
[61] Yang X-L, Hu B, Wang B, Wang M-N, Zhang Q, Zhang
W, et al. Isolation and characterization of a novel bat
coronavirus closely related to the direct progenitor of
severe acute respiratory syndrome coronavirus. J Virol.
2016; 90:3253-3256. https://doi:10.1128/JVI.02582-15
[62] Gralinski LE, Menachery VD. Return of the
Coronavirus: 2019-nCoV. Viruses. 2020; 12:135.
https://doi:10.3390/v12020135
[63] Armijos-Jaramillo V, Yeager J, Muslin C, Perez-Castillo
Y. SARS-CoV-2, an evolutionary perspective of inter-
action with human ACE2 reveals undiscovered amino
acids necessary for complex stability. bioRxiv preprint
https://doi.org/10.1101/2020.03.21.001933
[64] Hoffmann M, Müller MA, Drexler JF, Glende J,
Erdt M, Gützkow T, et al. Differential sensitiv-
ity of bat cells to infection by enveloped RNA
viruses: coronaviruses, paramyxoviruses, filoviruses,
and influenza viruses. PLoS ONE. 2013; 8(8):e72942.
https://doi:10.1371/journal.pone.0072942
[65] Zhang T, Wu Q, Zhang Z. Probable pangolin ori-
gin of SARS-CoV-2 associated with the COVID-
19 outbreak. Curr Biol. 2020; 30:1346-1351.
https://doi.org/10.1016/j.cub.2020.03.022
[66] Li F. Structural analysis of major species barriers be-
tween humans and palm civets for severe acute respi-
ratory syndrome coronavirus infections. J Virol. 2008;
82(14):6984-6991. https://doi:10.1128/JVI.00442-08
[67] Lam TT-Y, Shum MH-H, Zhu H-C, Tong Y-G, Ni
X-B, Liao Y-S, et al. Identifying SARS-CoV-2-related
coronaviruses in Malayan pangolins. Nature. 2020.
https://doi:10.1038/s41586-020-2169-0
[68] Hofmann H, Pyrc K, van der Hoek L, Geier M, Berkhout
B, Pöhlmann S. Human coronavirus NL63 employs the
severe acute respiratory syndrome coronavirus recep-
tor for cellular entry. Proc Natl Acad Sci USA. 2005;
102(22):7988-7993. https://doi:10.1073/pnas.0409465102
[69] Hofmann H, Simmons G, Rennekamp AJ, Chaipan
C, Gramberg T, Heck E, et al. Highly conserved re-
gions within the spike proteins of human coronaviruses
229E and NL63 determine recognition of their respec-
tive cellular receptors. J Virol. 2006; 80(17):8639-8652.
https://doi:10.1128/JVI.00560-06
[70] Milewska A, Zarebski M, Nowak P, Stozek K,
Potempa J, Pyrc K. Human coronavirus NL63 uti-
lizes heparan sulfate proteoglycans for attachment
to target cells. J Virol. 2014; 88(22):13221-13230.
https://doi.org/10.1128/JVI.02078-14
[71] Glowacka I, Bertram S, Herzog P, Pfefferle S, Steffen I,
Muench MO, et al. Differential downregulation of ACE2
by the spike proteins of severe acute respiratory syn-
drome coronavirus and human coronavirus NL63. J Virol.
2010; 84(2):1198-1205. https://doi:10.1128/JVI.01248-09
[72] Wu K, Li W, Peng G, Li F. Crystal structure
of NL63 respiratory coronavirus receptor-binding do-
main complexed with its human receptor. Proc
Natl Acad Sci USA. 2009; 106(47):19970-19974.
https://doi.org/10.1073/pnas.0908837106
[73] Li W, Sui J, Huang I-C, Kuhn JH, Radoshitzky SR,
Marasco WA, et al. The S proteins of human coronavirus
NL63 and severe acute respiratory syndrome coron-
avirus bind overlapping regions of ACE2. Virology. 2007;
367:367-374. https://doi:10.1016/j.virol.2007.04.035
[74] Lin H-X, Feng Y, Wong G, Wang L, Li B, Zhao X,
et al. Identification of residues in the receptor-binding
domain (RBD) of the spike protein of human coron-
avirus NL63 that are critical for the RBD-ACE2 re-
ceptor interaction. J Gen Virol. 2008; 89:1015-1024.
https://doi:10.1099/vir.0.83331-0
[75] Lin H-X ,Feng Y, Tu X, Zhao X, Hsieh C-H, Grif-
fin L, et al. Characterization of the spike protein
of human coronavirus NL63 in receptor binding and
pseudotype virus entry. Virus Res. 2011; 160:283-293.
https://doi:10.1016/j.virusres.2011.06.029
10
     Spike      Spike      Spike
Name Glycoprotein  Name Glycoprotein  Name Glycoprotein
                GenBank                GenBank                GenBank
SARS-CoV-Tor2 AAP41037.1 SARS-CoV PC4-115 AAV49719.1 Rhinolophus affinis CoV LYRa3 (SARS-like) AHX37569.1
SARS-CoV BJ01 AAP30030.1 SARS-CoV PC4-145 AAV49721.1 Rhinolophus affinis CoV LYRa11 (SARS-like) AHX37558.1
SARS-CoV CUHK-W1 AAP13567.1 SARS-CoV PC4-241 AAV49723.1 Bat SARS-like CoV Rs3367 AGZ48818.1
SARS-CoV Urbani AAP13441.1 SARS-CoV civet014 AAU04661.1 Bat SARS-like CoV Rs4874 ATO98205.1
SARS-CoV Frankfurt-1 AAP33697.1 SARS-CoV PC4-137 AAV49720.1 Bat SARS-like CoV WIV1 AGZ48828.1
SARS-CoV CUHK-AG01 AAP94737.1 SARS-CoV civet020 AAU04664.1 SARS-like CoV WIV16 ALK02457.1
SARS-CoV TW6 AAR87567.1 SARS-CoV PC4-127 AAU93318.1 Bat SARS CoV RaTG13 QHR63300.2
SARS-CoV TW11 AAR87512.1 SARS-CoV B039 AAV97993.1 Bat SARS-like CoV Rs7327 ATO98218.1
SARS-CoV HKU-39849 ADC35483.1 SARS-CoV PC4-205 AAU93319.1 Bat SARS-like CoV Rs9401 ATO98231.1
SARS-CoV-2 Wuhan-Hu-1 QHD43416.1 SARS-CoV PC4-199 AAV49722.1 CoV BtRs-BetaCoV/YN2018B QDF43825.1
SARS-CoV-2 CA-CDC-0139 QJV58828.1 SARS-CoV civet010 AAU04649.1 Bat SARS-like CoV RsSHC014 AGZ48806.1
SARS-CoV-2 France QJT72590.1 SARS-CoV civet019 AAU04662.1 Bat SARS-like CoV Rs4084 ATO98132.1
SARS-CoV-2 WHUHnCoV011 QIU82034.1 SARS-CoV A022 AAV91631.1 Bat SARS-like CoV Rs4231 ATO98157.1
SARS-CoV-2 CA-CZB-1248 QKE49268.1 Civet SARS-CoV 007/2004 AAU04646.1 SARS-CoV strain BtKY72 APO40579.1
SARS-CoV-2 CA-CZB-1033 QJQ38756.1 SARS-CoV A001 AAV97984.1 SARS-like CoV BatCoV/BB9904/BGR/2008 ALJ94036.1
SARS-CoV-2 France/10070SK QJT73010.1 PCoV GX-P2V QIQ54048.1 Bat CoV BM48-31/BGR/2008 (SARS-like) ADK66841.1
SARS-CoV-2 CA-CZB0103 QJE38330.1 PCoV GX-P4L QIA48614.1 CoV BtRl-BetaCoV/SC2018 QDF43815.1
SARS-CoV-2 BetaCoV/Wuhan/IPBCAMS-WH-05 QHU36864.1 PCoV GX-P5L QIA48632.1 BtRs-BetaCoV/HuB2013 AIA62310.1
SARS-CoV-2 CruiseA-18 QII57278.1 Bat SARS-CoV HKU3-1 AAY88866.1
SARS-CoV-2 CA-CZB-1105 QJS54754.1 Bat SARS-like CoV bat-SL-CoVZC45 AVP78031.1
Bat SARS-like CoV bat-SL-CoVZXC21 AVP78042.1
Bat SARS-CoV Rf1/2004 ABD75323.1
Bat SARS-like CoV Rf4092 ATO98145.1
Bat CoV Anlong-103 ARI44799.1
Bat CoV Anlong-112 ARI44804.1
Bat SARS-CoV Rp3/2004 AAZ67052.1
CoV BtRs-BetaCoV/YN2018C QDF43830.1
Bat CoV Rp/Shaanxi2011 AGC74165.1
Bat SARS-CoV Rm1 ABD75332.1
Table S1: GenBank accession numbers for the coronavirus sequences used in this study.
